Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Correaltion of Thrombolysis in Myocardial Infarction Risk Score and Angiographic Score in Patients With St-Elevation in Myocardial Infarction



Akhbari M1 ; Sanei H1 ; Sadeghi M1 ; Akbari M2 ; Sistan N3 ; Jafaripour I1 ; Benam MR1 ; Motamedi N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Epidemiology and Statistics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Chamran Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2009

Abstract

Background: Myocardial Infarction is a common and lethal disease, especially in first hours. Rapid and correct decision is essential for priority of advance therapies and this study follows the accuracy of a scoring system for this triage. The aim was to assess the correlation of Thrombolysis in Myocardial Infarction Risk score and Angio score in patients with ST Elevation Myocardial Infarction. Methods: In this cross sectional study, 240 patients with ST elevation myocardial infarction from CCU of universal hospitals participated in the study. Thrombolysis in myocardial infarction risk score was calculated and during 2 month they underwent angiography and follow up. Findings: Mean age was 60.02 and 79 patients were female. Correlation between thrombolysis in myocardial infarction risk and angio score was significant (P < 0.001). Correlation between ejection fraction and thrombolysis in myocardial infarction risk score (P < 0.001) and angio score with age (P < 0.001) was significant too. There was no significant correlation between Angio score and recurrent angina (P = 0.143), rehospitalization (P = 0.524) and death (P = 0.179). Pearson’s correlation showed significant relation between thrombolysis in myocardial infarction risk score and angio score (P < 0.001, r = 0.556). Conclusion: This correlation shows that thrombolysis in myocardial infarction risk score probably can be used for evaluating angiographic extent of coronary artery disease. Simple clinical use of this score at bedside if confirms with a prospective cohort study, makes this score a method to stratify patients in high and low risk groups and accordingly diagnostic-therapeutic strategies. © 2009, Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. The Comparison of Procedural and Clinical Outcomes of Thrombolytic-Facilitated and Primary Percutaneous Coronary Intervention in Patients With Acute St-Elevation Myocardial Infarction (Stemi): Findings From Prove/Acs Study, ARYA Atherosclerosis (2020)
2. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
3. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
4. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
5. Predictors of Mortality for Patients With St-Elevation Myocardial Infraction After 2-Year Follow-Up: A St-Elevation Myocardial Infarction Cohort in Isfahan Study, Advanced Biomedical Research (2022)
6. Background and Design of a 5-Year St Elevation Myocardial Infarction Cohort in Isfahan, Iran: Semi-Ci Study, ARYA Atherosclerosis (2022)
7. Effective Factors in Door-To-Needle Time for Streptokinase Administration in Patients With Acute Myocardial Infarction Admitted to the Emergency Department, Trauma Monthly (2016)
8. Effect of Streptokinase on Short-Term Outcomes in the Acute Myocardial Infarction With St-Segment Elevation, Journal of Reports in Pharmaceutical Sciences (2014)
Experts (# of related papers)
View all Related Experts
Masoumeh Sadeghi (41)
Nizal Sarrafzadegan (27)
Other Related Docs
9. Clinical, Laboratory, and Procedural Predictors of Slow Flow/No Reflow Phenomenon After Emergency Percutaneous Coronary Interventions in St-Elevated Myocardial Infarction, Egyptian Heart Journal (2024)
10. Determination of Shock Index and Age Shock Index Cut-Off Points in Patients With St-Segment Elevation Myocardial Infarction: Semi-Ci Study, International Journal of Cardiovascular Sciences (2024)
11. High Sensitive C-Reactive Protein Serum Levels in Patients With Acute Coronary Syndrome, Journal of Isfahan Medical School (2012)
12. Clinical Characteristics, Management and 1-Year Outcomes of Patients With Acute Coronary Syndrome in Iran: The Iranian Project for Assessment of Coronary Events 2 (Ipace2), BMJ Open (2015)
13. Survey of Coronary Catheterization Laboratory Activity in Iran During the Coronavirus Disease-2019 Pandemic, ARYA Atherosclerosis (2021)
14. Non-Administration of Thrombolytic Agents in Acute Myocardial Infarction Patients in Hajar Hospital, Shahrekord, Iran: Prevalence Rate and Causes, ARYA Atherosclerosis (2013)
15. Analysis of Traditional Risk Factors on St-Segment Elevation Myocardial Infarction Characteristics; [بررسی عوامل خطر سنتی مرتبط با ویژگیهای بالینی بیماران انفارکتوس میوکارد با بالارونده قطعه St], Journal of Isfahan Medical School (2024)
16. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
17. The Pattern of In-Hospital Mortality of Myocardial Infarction and Associated Factors in Iran: A National Study, Journal of Isfahan Medical School (2015)
18. A Cardiovascular Risk Assessment Model According to Behavioral, Psychosocial and Traditional Factors in Patients With St-Segment Elevation Myocardial Infarction (Cras-Mi): Review of Literature and Methodology of a Multi-Center Cohort Study, Current Problems in Cardiology (2023)
19. Effectiveness of Tenecteplase Versus Streptokinase in Treatment of Acute Myocardial Infarction: A Meta-Analysis, Tehran University Medical Journal (2018)
20. Atherogenic Index of Plasma: A Valuable Novel Index to Distinguish Patients With Unstable Atherogenic Plaques, Journal of Research in Medical Sciences (2022)
21. Diagnostic Performance of 64-Row Coronary Ct Angiography in Detecting Significant Stenosis As Compared With Conventional Invasive Coronary Angiography, ARYA Atherosclerosis (2013)
22. Association Between St-Segment Changes in Lead Avr and Angiographic Findings, Syntax Score, Short-Term and Intermediate Outcomes in Patients With Acute Coronary Syndrome: A Pilot Study, ARYA Atherosclerosis (2024)
23. Clinical and Cardiovascular Characteristics of Patients Suffering St-Segment Elevation Myocardial Infarction After Covid-19: A Systematic Review and Meta-Analysis, Current Problems in Cardiology (2023)
24. Is Impaired Fasting Glucose Associated With Increased Risk of Coronary Aterosclerosis?, Acta Medica Iranica (2008)
25. The Correlation Between Coronary Artery Calcium Score With Diagnosis of Angina Pectoris in Patients With and Without Metabolic Syndrome, Candidates for Coronary Angiography; [ارتباط ًورُی کلسین شریاى کرًٍر در بیواراى با ٍ بذٍى سٌذرم هتابَلیک با تشخیص آًژیي صذری کاًذیذسیتی آًژیَگرافی کرًٍری], Journal of Isfahan Medical School (2022)
26. The Effect of Intracoronary Versus Intralesional Injection of Eptifibatide on Myocardial Perfusion Outcomes During Primary Percutaneous Coronary Intervention in Acute St-Segment Elevation Myocardial Infarction; a Randomized Clinical Trial Study, ARYA Atherosclerosis (2019)
27. Long-Term Clinical Outcomes of the Left Ventricular Thrombus in Patients With St Elevation Anterior Myocardial Infarction, ARYA Atherosclerosis (2015)
28. Short-Time Survival Rate of Acute Myocardial Infarction in Elderly Patients in Isfahan City, Iran, Journal of Isfahan Medical School (2014)
29. Cardiovascular Disease in the Eastern Mediterranean Region: Epidemiology and Risk Factor Burden, Nature Reviews Cardiology (2018)
30. Evaluation of Fibrinolytic Medical Therapy for Patients With Acute Myocardial Infarction, ARYA Atherosclerosis (2012)
31. Relationship Between Complete Revascularization and Survival After Post-Infarction Ventricular Septal Rupture, ARYA Atherosclerosis (2023)
32. Anti-Streptokinase Antibody Detection Before and Immediately After Streptokinase Therapy in Patients With Myocardial Infarction, Iranian Journal of Immunology (2006)
33. Aspirin Resistance Status As Determined by Urinary Thromboxane B 2 (Txb2) Level in Patients With Ischemic Heart Disease and Its Relationship With Severity of Coronary Artery Disease, Journal of Isfahan Medical School (2011)
34. Comparison of Survival Rate and Complications of Percutaneous Coronary Intervention, Coronary Artery Bypass Graft, and Medical Treatment in Patients With Left Main And/Or Three Vessel Diseases, ARYA Atherosclerosis (2020)
35. Comparison of No-Reflow Phenomenon After Percutaneous Coronary Intervention for Acute Myocardial Infarction Between Smokers and Nonsmokers, Journal of Research in Medical Sciences (2014)
36. Reperfusion Therapies and In-Hospital Outcomes for St-Elevation Myocardial Infarction in Europe: The Acvc-Eapci Eorp Stemi Registry of the European Society of Cardiology, European Heart Journal (2021)
37. Secular Trends in Cardiovascular Mortality in Iran, With Special Reference to Isfahan, Acta Cardiologica (1999)
38. Seasonal Pattern in Admissions and Mortality From Acute Myocardial Infarction in Elderly Patients in Isfahan, Iran, ARYA Atherosclerosis (2014)
39. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
40. Assessment of Lytic Therapy Effect in Patients With Intermediate-High Risk Pulmonary Embolism for Prevention of Chronic Thromboembolic Pulmonary Hypertension: A Randomized, Double-Blind Trial, Health Science Reports (2024)
41. The Effects of Trinitroglycerin Injection on Early Complications of Angiography, ARYA Atherosclerosis (2012)
42. Prediction of Short-Term Clinical Outcome of Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome Through Myeloperoxidase Levels, ARYA Atherosclerosis (2014)
43. Comparing Efficacy of Receiving Different Doses of Eptifibatide in Bleeding After Percutaneous Coronary Intervention in Patients With Myocardial Infarction, ARYA Atherosclerosis (2019)
44. Age at Menarche and Risk of Premature Coronary Artery Disease: Results From Iran Premature Coronary Disease (Ipad) Study, Archives of Gynecology and Obstetrics (2025)
45. Current Status of the Clinical Epidemiology of Myocardial Infarction in Men and Women: A National Cross-Sectional Study in Iran, International Journal of Preventive Medicine (2015)
46. The Relationship of Coronary Heart Disease and Valvular Heart Disease in Patients With Stable Angina, Journal of Isfahan Medical School (2017)
47. Value of Coronary Artery Calcium Scoring in Iranian Patients Suspected to Coronary Artery Disease, Acta Medica Iranica (2015)
48. Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes After Percutaneous Coronary Intervention in Acute Stemi Patients: A Randomized Double Blind Clinical Trial, ARYA Atherosclerosis (2023)
49. The Correlation Between Early Complications of Percutaneous Coronary Intervention and High Sensitive C-Reactive Protein, ARYA Atherosclerosis (2013)
50. Heart Rate and Cardiovascular Events: A Nested Case-Control in Isfahan Cohort Study, Archives of Iranian Medicine (2014)